Skip to content

CapEx at other companies

Abbott logo
AbbottABT
$399M-17.6%
TFX
TeleflexTFX
$18.79M-22.1%
Boston Scientific logo
Boston ScientificBSX
$177M-5.3%
Medtronic logo
MedtronicMDT
$488M+6.3%
LivaNova logo
LivaNovaLIVN
$14.29M+32.4%
ICU Medical logo
ICU MedicalICUI
$11.3M-22.7%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.37B-18.0%
Enterprise value$4.4B-12.5%
P/S2.5×-0.5×

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's capex?
Haemonetics (HAE) reported capex of $17.66M in Q1 2026.
How has Haemonetics's capex changed year-over-year?
Haemonetics's capex increased by 12.9% year-over-year, from $15.64M to $17.66M.
What is the long-term trend for Haemonetics's capex?
Over 4 years (2022 to 2026), Haemonetics's capex has grown at a -23.7% compound annual growth rate (CAGR), from $96.51M to $32.78M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.